Next Article in Journal
Understanding Customer Experience and Satisfaction through Airline Passengers’ Online Review
Next Article in Special Issue
Well-Governed Sustainability and Financial Performance: A New Integrative Approach
Previous Article in Journal
The Alfredo Namitete Agroecology Credit System: A New Business Model That Supports Small-Scale Lending
Previous Article in Special Issue
Environmental Protection and Corporate Responsibility: The Perspectives of Senior Managers and CxOs in China
 
 
Article
Peer-Review Record

A Hybrid MCDM Model for Evaluating Strategic Alliance Partners in the Green Biopharmaceutical Industry

Sustainability 2019, 11(15), 4065; https://doi.org/10.3390/su11154065
by Mu-Hsin Chang 1, James J. H. Liou 2,* and Huai-Wei Lo 1
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Sustainability 2019, 11(15), 4065; https://doi.org/10.3390/su11154065
Submission received: 25 June 2019 / Revised: 18 July 2019 / Accepted: 25 July 2019 / Published: 27 July 2019
(This article belongs to the Special Issue Sustainability in Corporate Governance and Strategic Management)

Round 1

Reviewer 1 Report

I have gone through the paper this is interesting but a little bit complicated to the reader. 

What is the motivation of the study regarding the research question and objectives? 

Why do you believe this is a novel study through there are many studies have been investigating these strategic issues in the same or other industry?

The eight experts from the same company how could you avoid the biasedness of the study?

What types of question have been asked the expert?

Table 8, 9 and 10 are very complicated to the reader because of many dimensions. 

What are the finding and contribution that we like to believe, the study has managerial implications because technological industry must need innovation capability?

No theoretical discussion didn't support the resources and innovation of the study.  

Show the finding with figure 1. 

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Reviewer 2 Report

please clarify the following points.

What is green-biopharmaceutical industry?

Why studying strategic alliance is important in the green-biopharmaceutical industry? It needs further justification/explanation.

What is the basis of considering green biopharmaceutical industry energy intensive? What are the criteria?

Please provide the details of the process that led to the selection of the criteria presented in the figure 1.


Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Round 2

Reviewer 1 Report

The explanation extensively answered the questions of my mine. 

Back to TopTop